KRAS and non-small cell lung carcinoma: Enhanced expression of miR-21 in the lungs of transgenic mice potentiated formation of non-small cell lung cancers driven by an activated K-Ras oncogene [31], while homozygous deletion of the miR-21 gene in mice reduced the incidence of lung tumours in the same K-Ras driven model [31].